Research Protocol · Live
Vial · 10 mg
Research duration
Per vial
Cadence
DAILYPer dose
1 mg
Per-administration dose
◀ DRAG TO SCRUB ▶
5-Amino-1MQ 10mgResearch Peptide
Small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor, 10mg per vial. Studied in preclinical metabolic research for its role in the NAD⁺ salvage pathway and adipocyte energy metabolism.
Assayed Purity
99.00%
Method
HPLC
Certificate
Coming soon$10.50 / mg
Not eligible for Mystery Week
This product stays at its regular or volume price.
In stock, ships from Sydney
For research use only. Not for human consumption. By purchasing this product, you confirm it will be used solely for legitimate research purposes.
Small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor, 10mg per vial. Studied in preclinical metabolic research for its role in the NAD⁺ salvage pathway and adipocyte energy metabolism.
5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) — it is not a peptide. NNMT consumes the methyl donor SAM to methylate nicotinamide into 1-methylnicotinamide, diverting nicotinamide away from the NAD⁺ salvage pathway. In published preclinical work, inhibiting NNMT is associated with elevated intracellular NAD⁺ and SAM, reduced lipogenesis and smaller adipocytes in cell and diet-induced-obese rodent models, and is studied in the context of insulin sensitivity and muscle function. It is natively an orally-active compound. All figures and pathways described are preclinical research observations. For research use only. Not for human consumption.
